Endangered marine mammals — seals, dolphins, whales, and otters — are almost as vulnerable as humans in becoming infected from
Read more
ACE2
A SARS-CoV-2 spike protein adjuvant vaccine candidate produces durable rapid protection in vivo
The ongoing coronavirus disease 2019 (COVID-19) pandemic has spurred intensive vaccine-related research. As yet, no targeted, safe and effective antivirals
Read more
Two potent SARS-CoV-2 neutralizing antibodies effective against B.1.351 and B.1.1.7 variants
By analyzing the cryoEM structures of antibodies against the SARS-CoV-2 virus, researchers report that the neutralizing capabilities of two antibodies
Read more
A pangolin coronavirus spike glycoprotein sheds light on SARS-CoV-2’s evolution
As the coronavirus disease 2019 (COVID-19), caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), continues to wreak havoc
Read more
Clonally expanded plasma cell lineages in SARS-CoV-2 produce specific neutralizing antibodies
The immune response to infection by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), the cause of the ongoing coronavirus
Read more
Vaccine candidate containing tetanus toxoid potentially protective against SARS-CoV-2
Researchers from Cuba, China, and France have demonstrated the potential of coupling a viral antigen with the tetanus toxoid protein
Read more
Could graphene be an effective antiviral platform against SARS-CoV-2?
The coronavirus disease 2019 (COVID-19) pandemic continues to take a heavy toll on human life and economic well-being. Caused by
Read more
E484K mutation is potentially associated with SARS-CoV-2 adaptive fitness
A team of Brazilian scientists has recently conducted genomic and phylogenetic analyses of the severe acute respiratory syndrome coronavirus 2
Read more